article thumbnail

Carnivorous squirrels documented in California

Science Daily: Pharmacology News

California ground squirrels hunt, kill and eat voles, reveals a new study documenting evidence of widespread carnivorous behavior among squirrels.

305
305
article thumbnail

First case of Down syndrome in Neanderthals documented in new study

Science Daily: Pharmacology News

A new study documents the first case of Down syndrome in Neanderthals and reveals that they were capable of providing altruistic care and support for a vulnerable member of their social group.

319
319
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ice cores provide first documentation of rapid Antarctic ice loss in the past

Science Daily: Pharmacology News

Researchers have uncovered the first direct evidence that the West Antarctic Ice Sheet shrunk suddenly and dramatically at the end of the Last Ice Age, around eight thousand years ago.

Research 363
article thumbnail

Rare fossils of extinct elephant document the earliest known instance of butchery in India

Science Daily: Pharmacology News

Scientists have discovered the earliest evidence of animal butchery by humans in India.

318
318
article thumbnail

FDA staff hold ‘major concerns’ with Brainstorm ALS therapy, documents show

BioPharma Drive: Drug Pricing

Agency scientists flagged numerous issues with Brainstorm’s stem cell treatment ahead of a high-profile Wednesday meeting of expert FDA advisers.

FDA 307
article thumbnail

FDA documents hint at ‘uphill battle’ for broad approval of Sage’s depression drug

BioPharma Drive: Drug Pricing

The newly posted documents show the agency had concerns about the side effects experienced by people with clinical depression who took Sage’s drug, Zurzuvae.

FDA 157
article thumbnail

Reports Document FDA Review Delays: What Drugmakers Should Know Now

FDA Law Blog: Drug Discovery

By John W.M. Claud & Michelle L. Butler Recent reductions in force (RIFs) and leadership changes at FDA are already affecting key agency functionsand as the administration plans a broader reorganization, the impact will likely grow. One area drawing increasing attention is how these changes will affect the drug development and review process.

FDA 64